Full-Time

Collections Specialist

Guardian Pharmacy Services

Guardian Pharmacy Services

1,001-5,000 employees

Decentralized LTC pharmacy with national support

Compensation Overview

$24 - $26/hr

+ 401(k) company match

Minneapolis, MN, USA

Hybrid

Remote work is available after 30 days of on-site training in Eden Prairie, Minnesota.

Category
Accounting (1)
Required Skills
Customer Service
HIPAA

Get referred to Guardian Pharmacy Services

See people who can refer or advise you

Requirements
  • A high school diploma or GED is required.
  • A pharmacy technician license, certification, or registration is required according to state requirements; National Certification through the Pharmacy Technician Certification Board is preferred and may be required for pharmacy-specific work.
  • At least 1 year of related experience is required.
  • Advanced computer skills are required, with pharmacy information system experience preferred.
  • The ability to work independently and meet deadlines is required.
  • Strong attention to detail and accuracy are required.
  • The ability to manage multiple tasks in a fast-paced, team-oriented environment while adhering to strict deadlines is required.
  • A quality-focused approach and the motivation to identify errors and investigate inaccuracies are required.
  • The ability to interact effectively with others in an office environment, manage conflict, and handle stressful situations and deadlines is required.
Responsibilities
  • Process customer bills and insurance claims accurately and timely.
  • Assist with daily and month-end billing functions, procedures, and reporting.
  • Provide customer service to patients, caregivers, medical providers, and insurance carriers.
  • Research and establish patient eligibility coverage with insurance providers, including private individuals and government entities.
  • Reverify benefit coverage criteria for claims follow-up and enter or update patient and insurance information in the billing system.
  • Maintain and audit patient files and supporting documentation for third-party audits and payer and company compliance.
  • Enter patient information into the pharmacy system.
  • Respond to billing inquiries by phone or electronic communication and resolve issues involving insurance eligibility, coverage, and related benefits.
  • Support residents or responsible parties by running Medicare plan comparisons during open and special enrollment periods.
  • Review patient profiles, drug regimens, and insurance coverage to identify cost-saving options.
  • Complete daily census, admissions, discharges, and room changes for assigned facilities.
  • Process patient payments, returns, and credits, including transmitting individual credit card payments as needed.
  • Pursue payment from delinquent accounts and make payment arrangements when needed.
  • Research, identify, and organize requested audit documentation.
  • Perform prescription claims adjudication and communicate with insurance companies about rejected claims, eligibility, prior authorizations, and other issues.
  • Correct and rebill prescription claims as necessary.
  • Develop knowledge of pharmacy facility billing requirements involving Medicare, Medicaid, Prescription Drug Plans, and third-party insurance.
  • Use pharmacy information systems to process prior authorizations, resolve claim rejections, produce reports, and complete billing functions.
  • Rotate through other departments to gain functional knowledge of department workflows.
  • Follow applicable government regulations, including the Health Insurance Portability and Accountability Act.
  • Collaborate with team members to meet pharmacy service goals.
  • Perform other assigned essential functions and duties.
Desired Qualifications
  • Pharmacy information system experience is preferred.
  • National Pharmacy Technician Certification through the Pharmacy Technician Certification Board may be preferred or required depending on pharmacy-specific requirements.
Guardian Pharmacy Services

Guardian Pharmacy Services

View

Guardian Pharmacy Services runs a network of long-term care pharmacies in the United States using a local-autonomy model, where each pharmacy operates as a local business with some owner-ship by local managers while a national team provides centralized support. It dispenses medications and offers medication management, 24/7 access, advanced packaging, and clinical support from pharmacists who specialize in geriatric and complex care, backed by GuardianShield data analytics to aid facility decisions. The company serves residents in assisted living, memory care, skilled nursing, hospice, and related settings across 38 states, with a national footprint of over 53 pharmacies serving more than 204,000 residents. Its goal is to improve medication safety and adherence while reducing overall healthcare costs through tailored, community-focused care and scalable corporate resources.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Atlanta, Georgia

Founded

2004

Get referred to Guardian Pharmacy Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 2.2%, and residents reached 210,000.
  • August 6, 2026 guidance increased again after Wellness Concepts and Lexington launches.
  • Acquisitions and greenfields keep expanding Guardian’s footprint without sacrificing local leadership continuity.

What critics are saying

  • July 2026 IRA pricing cuts crushed organic revenue, masking underlying demand strength.
  • About 71% of 2025 revenue came from Medicare Part D, concentrating reimbursement exposure.
  • If drug pricing reforms deepen in 2027, Guardian’s growth model loses economic engine.

What makes Guardian Pharmacy Services unique

  • Decentralized local-ownership pharmacies, plus centralized support, drive faster market-specific execution.
  • GuardianShield and Guardian Compass turn LTC data into contracting and clinical advantage.
  • By August 2026, Guardian scaled to 61 pharmacies across 38 states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

401(k) Company Match

Paid Holidays

Paid Sick Leave

Paid Vacation

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Yahoo Finance
Aug 13th, 2026
Guardian Pharmacy Services grows revenue 2% in Q2 2026 despite IRA pricing impact

Guardian Pharmacy Services reported second quarter 2026 results, with revenue growing 2% through the first half of the year. Chief Executive Officer Fred Burke noted the company would have seen low double-digit revenue growth excluding IRA pricing reductions, which he described as a clearer indication of underlying business growth. The company attributed its performance to solid fundamentals across local markets and progress on strategic priorities, including geographic expansion. Burke emphasised that Guardian continues to execute well despite pricing pressures. The results covered the quarter ended 30 June 2026. Company executives, including Burke, Chief Operating Officer David Morris, and Chief Financial Officer Will Mudd, discussed the performance during an earnings call.

Business Wire
Jul 2nd, 2026
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts

Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

Yahoo Finance
May 10th, 2026
Guardian Pharmacy navigates IRA pricing changes with 19% gross profit growth in Q1

Guardian Pharmacy Services reported first-quarter 2026 revenue of $336.6 million, up 2% year over year, despite significant pricing pressure from the Inflation Reduction Act's new framework. CEO Fred Burke said the company experienced approximately 60% price declines on IRA-selected drugs, noting that revenue would have grown by low double digits without these government-mandated reductions. The company reported gross profit of $76 million, up 19% year over year, with adjusted EBITDA rising 27% to $29.8 million. Total residents increased 10% to approximately 207,000, with script volumes also up 10%. CFO David Morris attributed growth to organic expansion, acquisitions and plan optimisation efforts. Guardian raised its adjusted EBITDA guidance whilst maintaining its full-year revenue outlook following the quarter.

Yahoo Finance
May 8th, 2026
Guardian Pharmacy offsets 60% IRA-driven branded drug pricing decline with 2% Q1 revenue growth

Guardian Pharmacy Services reported 2% revenue growth in Q1 2026, offsetting a 60% decline in branded drug pricing from the Inflation Reduction Act through renegotiated payer contracts. The company updated full-year adjusted EBITDA guidance to $123 million–$127 million, reflecting a $3 million discrete first-quarter benefit. Underlying fundamentals remained strong, with 10% year-over-year growth in resident count and prescription volumes. However, operational complexity increased due to Medicare's new Transaction Facilitator platform, causing working capital timing shifts expected to normalise throughout the year. Results included $3.2 million in legal expenses for reimbursement advocacy, with an $8.5 million settlement to be recognised in Q2. Recent acquisitions dampened margins by 80 basis points. Management expects labour costs to rise modestly as the company invests in regional leadership whilst maintaining its acquisition pace.

Bitget
Mar 18th, 2026
Guardian's $21 synthetic secondary suggests undervaluation as 35% discount reflects earnings momentum

Guardian Pharmacy Services has priced a follow-on offering at $21 per share, raising approximately $181 million in a synthetic secondary. The offering price represents a 35% discount to the previous closing price of $32.59, though the stock had already declined 2.60% over the past month. The company reported strong 2025 results, with revenue of $1.45 billion (up 18%) and adjusted EBITDA of $115.1 million (up 53%). Management raised 2026 EBITDA guidance to $120–$124 million, but revenue projections remain flat at $1.40–$1.42 billion, signalling a growth slowdown. Guardian's shares trade at a trailing P/E of 55.19, with a market capitalisation near $2.20 billion. Analysts rate the stock a moderate buy with a price target around $32, indicating limited upside as the market has absorbed recent earnings surprises.